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Purkinje cells are one of the major types of neurons that form the
neural circuitry in the cerebellum essential for fine control of
movement and posture. During development, Purkinje cells also
are critically involved in the regulation of proliferation of progen-
itors of granule cells, the other major type of neurons in the
cerebellum. The process that controls differentiation of Purkinje
cells from their early precursors is poorly understood. Here we
report that two closely related LIM-homeobox genes, Lhx1 and
Lhx5, were expressed in the developing Purkinje cells soon after
they exited the cell cycle and migrated out of the cerebellar
ventricular zone. Double-mutant mice lacking function of both
Lhx1 and Lhx5 showed a severe reduction in the number of
Purkinje cells. In addition, targeted inactivation of Ldb1, which
encodes a cofactor for all LIM-homeodomain proteins, resulted in
a similar phenotype. Our studies thus provide evidence that these
transcription regulators are essential for controlling Purkinje cell
differentiation in the developing mammalian cerebellum.
CNS  development  embryo  mouse  transcription
The neural circuitry in the cerebellum plays an essential rolein controlling movement and posture. Granule cells and
Purkinje cells constitute the two principal types of neurons that
form this circuitry. One major challenge in understanding de-
velopment of the cerebellum is to elucidate the mechanisms
underlying the generation of these cells.
The generation of the granule cells has been known to involve
intricate regulations by a number of signaling molecules and
transcription factors. The Shh signaling molecule (1, 2) and its
downstream transcription factor Gli2 (3), as well as the Notch
signaling pathway (4) and other transcription factors such as
Ru49/Zipro1 (5), Zic1, and Zic2 (6, 7), are important for
regulation of proliferation of the granule cell progenitors. The
BMP signaling molecules (8–10) and transcription factors such
as Math1 (11, 12) and NeuroD (13) are critically involved in the
specification or differentiation of the granule cells.
The factors that control the generation of Purkinje cells are
largely unknown (for reviews, see refs. 14–17). Recent studies
have revealed that Ptf1a, a basic helix–loop–helix transcription
factor, is required for the specification of progenitors of all
cerebellar GABAergic neurons, including Purkinje cells, in the
ventricular zone of the cerebellum (18, 19). However, the factors
that regulate further differentiation of Purkinje cells after they
become postmitotic and migrate out of the ventricular zone have
remained unclear.
The LIM-homeodomain proteins represent transcription fac-
tors that play essential roles in the differentiation of many
specific types of neurons throughout the developing central
nervous system (20, 21). They function in the context of protein
complexes that involve a key cofactor called Ldb1 (22–24). RNAs
encoding two closely related LIM-homeodomain proteins, Lhx1
and Lhx5, previously have been detected in Purkinje cells in
postnatal and adult mice and rats (refs. 25 and 26 and data not
shown). More recently, the expression of Lhx1 and Lhx5 proteins
and of Lhx1- and Lhx5-directed Egfp reporters have been
observed in developing Purkinje cells soon after they exit the cell
cycle in the cerebellum (27). To begin to address the role of
LIM-homeodomain proteins in cerebellar development, we ex-
amined the expression of Lhx1, Lhx5, and Ldb1 mRNAs in the
developing cerebellum. We found that all are expressed in the
developing Purkinje cells. Moreover, our analysis of mutant
mouse embryos lacking function of these genes revealed that
they are essential for Purkinje cell differentiation in the devel-
oping cerebellum.
Results
Expression of Lhx1 and Lhx5 mRNAs in the Developing Purkinje Cells.
The Purkinje cells are derived from progenitors in the ventric-
ular neuroepithelium of the developing cerebellar anlage (28).
During mouse embryonic development, Purkinje cells are born
between embryonic day (E)11 and E13, as their progenitors exit
the cell cycle and start to migrate out of the ventricular zone (15).
By in situ hybridization, we detected mRNAs encoding Lhx1 and
Lhx5, two closely related LIM-homeodomain transcription fac-
tors, in cells that had just migrated out of the ventricular zone of
the cerebellum at E12.5 (Fig. 1 A and E). Lhx1 and Lhx5mRNAs
continuously were present in the migrating cells that had left the
ventricular zone at E14.5 (Fig. 1 B and F). By E16.5 and E18.5,
we found Lhx1 mRNA in the emerging Purkinje cell layer of the
cerebellum (Fig. 1 C andD), whereas the expression of Lhx5 was
reduced (Fig. 1G and H). The activity of the Lhx1 gene also was
analyzed in Lhx1LacZ/embryos, in which a part of one copy of
the Lhx1 gene was replaced by a LacZ reporter (29). 5-Bromo-
4-chloro-3-indolyl--D-galactopyranoside (X-gal) staining re-
vealed that -galactosidase, a product of the LacZ reporter gene,
was expressed in the cerebellum (Fig. 1 I and J) in a pattern
identical to that of Lhx1 mRNA shown by in situ hybridization
(Fig. 1 A and C). We next performed X-gal and anti-5-bromo-
2-deoxyuridine (BrdU) double staining of sections from
Lhx1LacZ/ embryos that also were pulse-labeled by BrdU. This
analysis allowed us to determine that Lhx1 was expressed only in
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BrdU-negative postmitotic cells in the differentiating zone but
not in BrdU-positive proliferating cells in the ventricular zone of
the cerebellum (Fig. 1K). The expression patterns of Lhx1 and
Lhx5mRNAs and Lhx1–LacZ reporter shown here are identical
to those of Lhx1 and Lhx5 proteins and Lhx1-and Lhx5–Egfp
reporters that have been described elsewhere (27).
Severe Reduction in Number of Purkinje Cells in Lhx1/Lhx5 Double
Mutants. Previous studies have revealed essential roles for Lhx1
and Lhx5 in neuronal differentiation in the developing spinal
cord and hippocampus (29, 30). The expression patterns of Lhx1
and Lhx5 in the cerebellum suggest that these factors may be
involved in controlling Purkinje cell differentiation. To deter-
mine the role of Lhx5 in development of the cerebellum, we
performed histological analysis in Lhx5-null mice. Most of the
Lhx5-null mutants die soon after birth, but a few survive to
adulthood (30, 31). The cerebellum of mutant E18.5 embryos
and adults was found to be indistinguishable from that of
wild-type controls (data not shown) (31). Germ-line deletions of
the Lhx1 result in early lethality of the mutant embryos that lack
anterior head regions, including the cerebellum (29, 32). In an
effort to analyze the role of Lhx1 in development of the
cerebellum, we generated two different conditional Lhx1mutant
alleles, Lhx1fx1 [supporting information (SI) Fig. 6] and Lhx1fx2
(33), by inserting loxP sites into introns flanking the Lhx1 coding
sequence. By crossing the Lhx1 conditional mutants with mice
that express the Cre recombinase controlled by regulatory
elements of either the Nestin (Lhx1fx1/fx1; Nes-Cre) or En-
grailed-1 (Lhx1fx2/fx2; En1Cre/) gene, we were able to target Lhx1
ablation to the cerebellum by E11.5 or E12.5 (SI Figs. 6 and 7).
However, histological analysis at E18.5 revealed no significant
defects in the developing cerebellum of these Lhx1-deficient
mutants (SI Figs. 8 and 9). The Lhx1fx1/fx1; Nes-Cre conditional
mutants died soon after birth, possibly because of a failure in
kidney function. Cre also was expressed in the developing kidney
in these mutants (data not shown), which may well impair the
function of Lhx1 that is essential for kidney development (32, 34,
35). The Lhx1fx2/fx2; En1Cre/ conditional mutant was viable to
adulthood and showed no abnormal phenotype.
Lhx1 and Lhx5 share high sequence similarity (36) and overlap-
ping expression patterns in the developing cerebellum (Fig. 1),
suggesting that these two genes may have redundant roles in the
development of the cerebellum. To examine this possibility, we
generated double-mutant embryos lacking expression of both Lhx1
and Lhx5 in the developing cerebellum. At E14.5, the cerebellum
of the Lhx1/Lhx5 double-mutant embryos (Lhx1fx1/LacZ, Nes-Cre;
Lhx5/)was small as compared to that of controls (wild type or any
embryos with at least one copy of the Lhx1 or Lhx5 gene intact)
(Fig. 2A andB). At this stage, the expression of the calcium-binding
protein calbindin signals the appearance of differentiated Purkinje
cells in the control embryos (15) (Fig. 2E). By contrast, the staining
of calbindin was absent in the cerebellum of the Lhx1/Lhx5 double-
mutant embryos (Fig. 2F). At E18.5, the cerebellum in Lhx1/Lhx5
doublemutants remained small as compared to that in the controls.
It lacked the Purkinje cell layer and the foliation that had emerged
in the controls (Fig. 2 C and D). Although a few calbindin-positive
cells were present in the dorsal region, Purkinje cells were largely
absent in Lhx1/Lhx5 double mutants as compared to the controls
(Fig. 2 G and H). Similar defects also were observed in Lhx1/Lhx5
double mutants in which a different Lhx1 conditional mutant allele
(Lhx1fx2) had been inactivated by Cre expressed under the control
of En1 regulatory elements (Lhx1fx2/LacZ, En1Cre/; Lhx5/) (SI
Figs. 9 and 10). In those mutants, the staining of calbindin in the
cerebellum essentially was negative (SI Fig. 10F). In contrast to
calbindin, Pax2, a marker for cerebellar GABAergic interneurons
such as the basket and stellate cells (19, 37), was detected in many
cells of the Lhx1/Lhx5 double mutants as well as in the controls at
E14.5 (Fig. 2 I and J) and E18.5 (Fig. 2 K and L). Thus, inactivation
of Lhx1 and Lhx5 appears specifically to affect development of the
Purkinje cells in the cerebellum.
Defect in Purkinje Cell-Derived Cell–Cell Signaling in Lhx1/Lhx5 Double
Mutants.Despite the defect in Purkinje cell development, granule
cells, marked by Math-1 immunostaining (11), were specified
properly in Lhx1/Lhx5 double mutants (Fig. 3 A and B). Purkinje
cells have been reported to interact with granule cell precursors
via a Shh signaling pathway (1–3). Gli1, a Shh target gene, was
detected in both Purkinje and granule cells of control embryos
(3) (Fig. 3C). Consistent with the lack of Purkinje cells in
Lhx1/Lhx5 double mutants, the expression ofGli1 was missing in








Fig. 1. Expression of Lhx1 and Lhx5 genes in the developing mouse cere-
bellum. Lhx1 (A–D) and Lhx5 (E–H) mRNAs were detected in E12.5 (A and E),
E14.5 (B and F), E16.5 (C and G), and E18.5 (D and H) embryos by in situ
hybridization. -Galactosidase expressed from a LacZ reporter gene inserted
into the Lhx1 gene locus was analyzed in E12.5 (I) and E16.5 (J) Lhx1LacZ/
embryos by X-gal staining. (K) A section of the cerebellum from a BrdU-
injected E12.5 Lhx1LacZ/ embryo double labeled with X-gal staining (blue) to
detect the activity of the LacZ reporter gene and with anti-BrdU staining
(brown) to monitor proliferating cells. Arrows in A–F and I–K point at the
region where Lhx1 or Lhx5was expressed. Arrowheads inA, E, andK show the









Fig. 2. Defects of the cerebellum in Lhx1/Lhx5 double mutants (Lhx1fx1/LacZ;
Nes-Cre; Lhx5/). The cerebellum of mutant embryos (B, D, F, H, J, and L), as
compared with that of control embryos (A, C, E, G, I, and K), was analyzed by
hematoxylin and eosin staining (A–D) and immunostaining of calbindin (E–H)
and Pax2 (I–L) at E14.5 (A,B,E, F, I, and J) and E18.5 (C,D,G,H,K, and L). Arrows
in A and B point at the cells of the developing deep cerebellar nuclei.
Arrowheads in C, E, and G point out the developing Purkinje cells in the
cerebellum. The arrowhead in H shows residual calbindin-positive cells
present in the Lhx1/Lhx5 double mutants. (Scale bar: 100 m.)








Disappearance of Lhx1-Expressing Cells in the Cerebellum of Lhx1/
Lhx5 Double Mutants. To follow the cells that normally express
Lhx1 in the cerebellum of the Lhx1/Lhx5 double mutants, we
analyzed the activity of -galactosidase expressed from the LacZ
reporter gene that replaced the Lhx1 coding sequence. At E12.5,
-galactosidase activity was detected in postmitotic cells that had
migrated out of the ventricular zone of the developing cerebel-
lum, but the staining was significantly reduced in Lhx1/Lhx5
double mutants compared to that of the controls (Fig. 4 A and
B). At E13.5, E14.5, and E15.5, the -galactosidase-positive cells
were largely missing in the cerebellum of Lhx1/Lhx5 double
mutants, whereas they were present in the controls (Fig. 4 C and
D; and SI Fig. 11). Because -galactosidase-positive cells still
were detected in other brain regions of the Lhx1/Lhx5 double
mutants (Fig. 4D), it appeared that the cells that normally
express Lhx1 are competent for maintaining Lhx1 expression in
the absence of Lhx1 and Lhx5 function. Our results suggest that
these cells may start to disappear soon after they migrate out of
the ventricular zone of the cerebellum in Lhx1/Lhx5 double
mutants and subsequently are largely eliminated.
Defect in Purkinje Cell Development in Ldb1 Conditional Mutants.The
function of LIM-homeodomain proteins is mediated by the
obligatory cofactor Ldb1 (22). Ldb1 mRNA was expressed
extensively in the developing cerebellum (SI Fig. 12). A germ-
line deletion of Ldb1 causes very early embryonic lethality (24).
In an effort to analyze the role of Ldb1 in the development of the
cerebellum, we generated a conditional allele by inserting loxP
sites into the Ldb1 locus flanking the Ldb1 coding sequence (SI
Fig. 12) (38). To target Ldb1 deletion in postmitotic neurons in
the developing cerebellum, we crossed the Ldb1 conditional
mutants with theNes-Cremice. At E18.5, the cerebellum of the
conditional Ldb1 mutants appeared small and lacked the folia-
tion seen in control embryos (Fig. 5 A and B). Calbindin-positive
Purkinje cells were greatly reduced in number as compared to
those in the controls (Fig. 5 C andD). Thus, the deletion of Ldb1
resulted in a cerebellar phenotype that resembled that of Lhx1/
Lhx5 double mutants.
Discussion
Our results show that the LIM-homeobox genes Lhx1 and Lhx5
were expressed in precursors that just exited the cell cycle and
migrated out of the cerebellar ventricular zone to assume the
Purkinje cell identity. When the function of both Lhx1 and Lhx5
was inactivated, the differentiation of most of these postmitotic
cells was compromised, resulting in a severe reduction in number
of Purkinje cells. Thus, the LIM-homeodomain factors encoded
by these two genes play essential roles in the differentiation of
Purkinje cells in the developing cerebellum. In addition, our
study has underscored the obligatory function of the Ldb1
cofactor in this process.
A number of factors are known to be involved in Purkinje cell
migration or survival. The signaling molecule reelin and its
downstream transducer Dab1 are essential for the regulation of
Purkinje cell migration (39–41). Survival of Purkinje cells is
mediated by genes encoding nuclear factors Ror- (42, 43) and
Nna1 (44), and by neurotrophic factors such as the nerve growth
factor, brain-derived neurotrophic factor, ciliary neurotrophic
factor, neurotrophin-4/5, and acetylcholine (45, 46). Most re-
cently, the transcription factor Ptf1a has been shown to be
required for the specification of progenitors of all GABAergic
neurons, including Purkinje cells in the ventricular zone of the
developing cerebellum (18, 19). Our studies went beyond these
analyses in defining factors such as Lhx1 and Lhx5 that were
directly involved in Purkinje cell differentiation. This finding
opens a passage toward disclosing the complex genetic program
that controls the identity of this important type of neurons in the
developing central nervous system.
Despite the severe reduction in number of Purkinje cells in
Lhx1/Lhx5 double mutants (Lhx1fx1/LacZ, Nes-Cre; Lhx5/),
a few calbindin-positive cells were present in the dorsal region
A B
C D
Fig. 3. Purkinje cell-derived cell–cell signaling defect in the cerebellum of
Lhx1/Lhx5 double mutants. (A and B) At E18.5, the granule cells in the
developing cerebellum of both control (A) and Lhx1/Lhx5 double-mutant (B)
embryos were labeled by immunostaining of Math1 (arrowheads). (C and D)
Gli1 mRNA was detected by in situ hybridization in the Purkinje (arrows) and
granule (arrowheads) cells of control embryos (C) but was largely missing in
Lhx1/Lhx5 double-mutant embryos (D). Arrowheads in D point at the perim-
eter of the cerebellum. (Scale bar: 100 m.)
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C D
Fig. 4. Gradual reduction of Purkinje cells expressing the Lhx1–LacZ reporter
gene in the cerebellum of Lhx1/Lhx5 double mutants. Cells expressing the
Lhx1–LacZ reporter gene in the cerebellum of control (A and C) and Lhx1/Lhx5
double-mutant (B and D) embryos were labeled by X-gal staining for -
galactosidase activity (arrows). (A and B) E12.5. (C and D) E14.5. Arrowheads
in D point at the perimeter of the cerebellum. (Scale bar: 100 m.)
A B
C D
Fig. 5. Defects in the development of the cerebellum in Ldb1 conditional
mutants. E18.5 conditional Ldb1 mutant (B and D) and control (A and C)
embryos were analyzed by hematoxylin and eosin (A and B) and by immuno-
staining of calbindin (C and D). (Scale bar: 100 m.)
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of the cerebellum. The presence of these cells suggests that
some of the precursors might escape the conditional inactiva-
tion of function of Lhx1 and eventually undergo proper
differentiation. Consistent with this idea, the calbindin-
positive cells rarely were observed when we used the En1Cre
allele for inactivation of Lhx1 (Lhx1fx2/LacZ, En1Cre/; Lhx5/,
see SI Fig. 10). In these double mutants, Cre likely was turned
on earlier than it was in mutants carrying the Nes-Cre allele.
The presence of reduced number of calbindin-positive cells in
the cerebellum of the Ldb1 conditional mutants likewise may
represent escapers, in this case caused by incomplete func-
tional inactivation of Ldb1.
Although the number of Purkinje cells was severely reduced in
Lhx1/Lhx5 double mutants, the cerebellar development appeared
normal after inactivation of either Lhx1 or Lhx5 alone, which
indicates that Lhx1 and Lhx5 are functionally redundant in con-
trolling Purkinje cell differentiation in the cerebellum. Functional
redundancy of LIM-homeodomain proteins including Lhx1 and
Lhx5 also has been observed in controlling differentiation of
subtypes of neurons in the developing spinal cord (47, 48).
Our study of Lhx1 and Lhx5, together with recent studies of
Ptf1a (18, 19, 49), suggests that similar mechanisms of tran-
scriptional regulation may operate in the cerebellum and the
spinal cord to control the generation of specific types of
neurons. In the cerebellum, Ptf1a is required for the specifi-
cation of progenitors of all GABAergic neurons, including
Purkinje cells (18, 19), in which Lhx1 and Lhx5 are expressed
and required for their normal differentiation. Ptf1a and Lhx1/
Lhx5 also are involved in the generation of subsets of
GABAergic interneurons in the dorsal spinal cord (48, 49).
Ptf1a and Lhx1/Lhx5 thus seem to function at sequential steps
in a same genetic program that controls the generation of
specific neuronal cell types in different regions of the devel-
oping central nervous system.
Materials and Methods
Animals. A conditional mutant allele of Lhx1 (Lhx1fx1) was
generated by inserting a loxP site and a loxP-f lanked neomycin-
resistance gene (Neo) cassette (loxP–Neo–loxP) into the first
and fourth introns of the Lhx1 gene, respectively, with the use
of homologous recombination in R1 mouse embryonic stem
cells (SI Fig. 6A). The targeted embryonic stem cell clones
were double-selected by G418 and gancyclovir and screened
with Southern hybridization analysis (SI Fig. 6B). Targeted
embryonic stem cells were injected into C57BL/6 (B6) blas-
tocysts to generate chimeric mice that carry the mutant allele
in the germ line. The chimeric mice were mated to wild-type
B6 mice to generate heterozygous animals (Lhx1fx1/) that
subsequently were crossed to produce homozygous Lhx1 con-
ditional mutants (Lhx1fx1/fx1). The Lhx1fx1/fx1 animals appeared
healthy. They were fertile and lived a normal lifespan. The
Lhx1fx1 allele was genotyped by PCR using a pair of primers
(L1-PsiS, 5-atcagaggtctgtgtggctcta-3; L1-PsiA, 5-tgctgagct-
gaagccatttcaga-3) f lanking the loxP site in the first intron of
the Lhx1 gene. The PCR amplified a 230-bp band from the
wild-type Lhx1 allele and a 280-bp band from the Lhx1fx1 allele,
respectively.
The Ldb1 conditional mutant allele was generated by inserting
a loxP site and a loxP–Neo–loxP cassette into the upstream region
and the ninth intron of the Ldb1 gene, respectively (SI Fig. 12D)
(38). Mice heterozygous for the Ldb1 conditional allele were
crossed with EII–Cre transgenic mice (50) that express Cre
transiently in the zygote to produce chimeric offspring with a
selective deletion of the loxP–Neo–loxP cassette. These chimeric
animals were mated to wild-type B6 mice to generate heterozy-
gous Ldb1 conditional mutants (Ldb1fx/) that did not contain
the Neo gene. The Ldb1fx/ mice were crossed to produce
homozygous Ldb1 conditional mutants (Ldb1fx/fx). The Ldb1fx/fx
mice were healthy, fertile, and lived a normal lifespan. The
Ldb1fx allele was genotyped by PCR using a pair of primers
(Ldb1-sense, 5-cagcaaacggaggaaacggaagatgtcag-3; Ldb1G, 5-
cttatgtgaccacagccatgcatgcatgtg-3) f lanking the loxP site in the
upstream region of the Ldb1 gene. The PCR amplified a 350-bp
band from the Ldb1 wild-type allele and a 400-bp band from the
Ldb1fx allele, respectively.
The generation of other transgenic mice used in this study,
which included another Lhx1 conditional mutant (Lhx1fx2/fx2)
(33), the Lhx1LacZ/ mutant (29), Lhx5 mutant (30), En1Cre/
(51), Nes-Cre (52), and Rosa26stopLacZ (53) mice, have been
described previously. The breeding, maintenance, and use of
animals were in compliance with guidelines approved by the
animal use committees of the National Institute of Child Health
and Human Development and the University of Texas M. D.
Anderson Cancer Center, respectively.
Histology, in Situ Hybridization, and Immunohistochemistry. To ob-
tain embryos for analysis, mice were mated and checked daily for
presence of vaginal plugs. Noon of the daywhen a plugwas detected
was designated as E0.5. Embryonic tissues were collected at various
developmental stages and fixed in 4% paraformaldehyde in 0.1 M
sodium phosphate buffer (pH 7.4) overnight at 4°C. After several
washes inPBS, tissueswere either dehydrated in ethanol, embedded
in paraffin, and sectioned at a thickness of 5 m or incubated in
30% sucrose in PBS, frozen in OCT compound (Sakura Finetek,
Torrance, CA), and sectioned at a thickness of 14 m. For
histological analysis, paraffin sections were stained with hematox-
ylin and eosin (Sigma, St. Louis, MO). For in situ hybridization,
either paraffin or frozen sections were hybridized with 33P-labeled
or digoxigenin-labeled probes, respectively, following published
procedures (54, 55). The probes used included those for Lhx1 (56),
Lhx5 (36), and Gli1 (3). Immunohistochemical staining of Math1
was performed on frozen sections by using a rabbit anti-Math1
antibody (1:100; a gift from Jane Johnson, University of Texas,
Dallas, TX) and theABC elite kit (Vector Laboratory, Burlingame,
CA) following procedures suggested by the manufacturer. Immu-
nostaining of calbindin was performed on paraffin sections with a
rabbit antibody (1:1,000; Chemicon, Temecula, CA) by following
published procedures (57). For immunodetection of Pax2, paraffin
sections were pretreated for antigen retrieval (PickCell 2100-
Retriever; Electron Microscopy Sciences, Hatfield, PA) and then
stained by using a rabbit antibody (1:200; Invitrogen, Carlsbad, CA)
and the ABC elite kit.
X-Gal Staining for -Galactosidase Activity. X-gal staining of whole
embryos (E12.5 or younger) was performed by following pub-
lished procedures (58). After the staining, embryos were post-
fixed in 4% paraformaldehyde in phosphate buffer (pH 7.4),
embedded in paraffin, and sectioned for further observation.
Tissues from embryos older than E12.5 were fixed in 4%
paraformaldehyde in phosphate buffer (0.1 M, pH 7.4) for 2–4
h at 4°C. After washes in PBS, the tissues were incubated in 30%
sucrose, frozen in OCT compound, and sectioned at a thickness
of 14 m. The sections were stained in the same solution used
for whole-embryo X-gal staining.
BrdU Labeling of Proliferating Cells.For labeling of proliferating cells
in developing embryos, pregnant females were injected i.p. with
BrdUdissolved in saline (100g per g of bodyweight; Sigma).After
an hour, the animals were killed. Embryos were dissected and first
processed for X-gal staining as described above. Thereafter, they
were paraffin-embedded, sectioned, and processed for detection of
BrdU by a peroxidase-labeled anti-BrdU antibody (Roche, India-
napolis, IN) following published procedures (30, 57).
Northern Blot Analysis. Total RNAs were isolated from the heads
of E11.5 Lhx1 conditional mutant (Lhx1fx1/fx1; Nes-Cre) and








control embryos with TriPure RNA isolation reagent (Roche).
The RNAs were separated on a gel, transferred to nylon
membrane, and hybridized with a 500-bp cDNA probe derived
from a part of the loxP-f lanked region of theLhx1 gene following
published procedures (57). The blot also was hybridized with a
probe corresponding to the GAPDH housekeeping gene to
ensure equal loading and transfer of the various RNA samples.
We thank Drs. Thomas Jessell (Columbia University, New York, NY)
and Jane Johnson (University of Texas, Dallas, TX) for providing
Lhx1LacZ/ mice and the antibody to Math1, respectively. We thank
SingPing Huang and Donna C. Morales for technical assistance. This
work was supported by funds from the Intramural Research Program of
the National Institute of Child Health and Human Development (to
H.W.), National Institutes of Health Grant HD30284, and the Ben F.
Love Chair for Cancer Research Fund (to R.R.B.).
1. Wechsler-Reya RJ, Scott MP (1999) Neuron 22:103–114.
2. Lewis PM, Gritli-Linde A, Smeyne R, Kottmann A, McMahon AP (2004) Dev
Biol 270:393–410.
3. Corrales JD, Rocco GL, Blaess S, Guo Q, Joyner AL (2004) Development
(Cambridge, UK) 131:5581–5590.
4. Solecki DJ, Liu XL, Tomoda T, Fang Y, HattenME (2001)Neuron 31:557–568.
5. Yang XW, Wynder C, Doughty ML, Heintz N (1999) Nat Genet 22:327–335.
6. Aruga J, Minowa O, Yaginuma H, Kuno J, Nagai T, Noda T, Mikoshiba K
(1998) J Neurosci 18:284–293.
7. Aruga J, Inoue T, Hoshino J, Mikoshiba K (2002) J Neurosci 22:218–225.
8. Alder J, Lee KJ, Jessell TM, Hatten ME (1999) Nat Neurosci 2:535–540.
9. Rios I, Alvarez-Rodriguez R, Marti E, Pons S (2004) Development (Cambridge,
UK) 131:3159–3168.
10. Qin L, Wine-Lee L, Ahn KJ, Crenshaw EB, III (2006) J Neurosci 26:1896–1905.
11. Ben-Arie N, Bellen HJ, Armstrong DL, McCall AE, Gordadze PR, Guo Q,
Matzuk MM, Zoghbi HY (1997) Nature 390:169–172.
12. Gazit R, Krizhanovsky V, Ben-Arie N (2004) Development (Cambridge, UK)
131:903–913.
13. Miyata T, Maeda T, Lee JE (1999) Genes Dev 13:1647–1652.
14. Hatten ME, Heintz N (1995) Annu Rev Neurosci 18:385–408.
15. Goldowitz D, Hamre K (1998) Trends Neurosci 21:375–382.
16. Wang VY, Zoghbi HY (2001) Nat Rev Neurosci 2:484–491.
17. Chizhikov V, Millen KJ (2003) Mol Genet Metab 80:54–65.
18. Hoshino M, Nakamura S, Mori K, Kawauchi T, Terao M, Nishimura YV,
Fukuda A, Fuse T, Matsuo N, Sone M, et al. (2005) Neuron 47:201–213.
19. PascualM, Abasolo I,Mingorance-LeMeur A,Martinez A, Del Rio JA,Wright
CV, Real FX, Soriano E (2007) Proc Natl Acad Sci USA 104:5193–5198.
20. Shirasaki R, Pfaff SL (2002) Annu Rev Neurosci 25:251–281.
21. Zhao Y, Malik N, Westphal H (2006) in Transcription Factors in the Nervous
System: Development, Brain Function, and Diseases, ed Thiel G (Wiley, Wein-
heim, Germany), pp 75–94.
22. Agulnick AD, Taira M, Breen JJ, Tanaka T, Dawid IB, Westphal H (1996)
Nature 384:270–272.
23. Thaler JP, Lee SK, Jurata LW, Gill GN, Pfaff SL (2002) Cell 110:237–249.
24. Mukhopadhyay M, Teufel A, Yamashita T, Agulnick AD, Chen L, Downs KM,
Schindler A, Grinberg A, Huang SP, Dorward D, Westphal H (2003) Devel-
opment (Cambridge, UK) 130:495–505.
25. Furuyama T, Inagaki S, Iwahashi Y, Takagi H (1994) Neurosci Lett 170:266–268.
26. Hayes WP, Yangco N, Chin H, Mill JF, Pu LP, Taira M, Dawid IB, Gallo V
(2001) J Neurosci Res 63:237–251.
27. Morales D, Hatten ME (2006) J Neurosci 26:12226–12236.
28. Hallonet ME, Le Douarin NM (1993) Eur J Neurosci 5:1145–1155.
29. Kania A, Johnson RL, Jessell TM (2000) Cell 102:161–173.
30. Zhao Y, Sheng HZ, Amini R, Grinberg A, Lee E, Huang S, Taira M, Westphal
H (1999) Science 284:1155–1158.
31. Paylor R, Zhao Y, Libbey M, Westphal H, Crawley JN (2001) Physiol Behav
73:781–792.
32. Shawlot W, Behringer RR (1995) Nature 374:425–430.
33. Kwan KM, Behringer RR (2002) Genesis 32:118–120.
34. Tsang TE, Shawlot W, Kinder SJ, Kobayashi A, Kwan KM, Schughart K, Kania
A, Jessell TM, Behringer RR, Tam PP (2000) Dev Biol 223:77–90.
35. Kobayashi A, Kwan KM, Carroll TJ, McMahon AP, Mendelsohn CL, Be-
hringer RR (2005) Development (Cambridge, UK) 132:2809–2823.
36. Sheng HZ, Bertuzzi S, Chiang C, Shawlot W, Taira M, Dawid I, Westphal H
(1997) Dev Dyn 208:266–277.
37. Maricich SM, Herrup K (1999) J Neurobiol 41:281–294.
38. Suleiman H, Heudobler D, Raschta AS, Zhao Y, Zhao Q, Hertting I, Vitzthum
H, Moeller MJ, Holzman LB, Rachel R, et al. (2007) Dev Biol 304:701–712.
39. D’Arcangelo G, Miao GG, Chen SC, Soares HD, Morgan JI, Curran T (1995)
Nature 374:719–723.
40. Sheldon M, Rice DS, D’Arcangelo G, Yoneshima H, Nakajima K, Mikoshiba
K, Howell BW, Cooper JA, Goldowitz D, Curran T (1997)Nature 389:730–733.
41. Howell BW, Hawkes R, Soriano P, Cooper JA (1997) Nature 389:733–737.
42. Dussault I, Fawcett D, Matthyssen A, Bader JA, Giguere V (1998) Mech Dev
70:147–153.
43. Hamilton BA, Frankel WN, Kerrebrock AW, Hawkins TL, FitzHugh W,
Kusumi K, Russell LB, Mueller KL, van Berkel V, Birren BW, et al. (1996)
Nature 379:736–739.
44. Fernandez-Gonzalez A, La Spada AR, Treadaway J, Higdon JC, Harris BS,
Sidman RL, Morgan JI, Zuo J (2002) Science 295:1904–1906.
45. Larkfors L, Lindsay RM, Alderson RF (1996) J Neurochem 66:1362–1373.
46. Mount HT, Dreyfus CF, Black IB (1994) J Neurochem 63:2065–2073.
47. Sharma K, Sheng HZ, Lettieri K, Li H, Karavanov A, Potter S, Westphal H,
Pfaff SL (1998) Cell 95:817–828.
48. Pillai A, Mansouri A, Behringer R, Westphal H, Goulding M (2007) Devel-
opment (Cambridge, UK) 134:357–366.
49. Glasgow SM, Henke RM, Macdonald RJ, Wright CV, Johnson JE (2005)
Development (Cambridge, UK) 132:5461–5469.
50. Lakso M, Pichel JG, Gorman JR, Sauer B, Okamoto Y, Lee E, Alt FW,
Westphal H (1996) Proc Natl Acad Sci USA 93:5860–5865.
51. Kimmel RA, Turnbull DH, Blanquet V, Wurst W, Loomis CA, Joyner AL
(2000) Genes Dev 14:1377–1389.
52. Tronche F, Kellendonk C, Kretz O, Gass P, Anlag K, Orban PC, Bock R, Klein
R, Schutz G (1999) Nat Genet 23:99–103.
53. Soriano P (1999) Nat Genet 21:70–71.
54. Robinson GW, Wray S, Mahon KA (1991) New Biol 3:1183–1194.
55. Schaeren-Wiemers N, Gerfin-Moser A (1993) (1993)Histochemistry 100:431–440.
56. Fujii T, Pichel JG, Taira M, Toyama R, Dawid IB, Westphal H (1994) Dev Dyn
199:73–83.
57. Zhao Y, Morales DC, Hermesz E, Lee WK, Pfaff SL, Westphal H (2006)Mech
Dev 123:605–613.
58. Sanes JR, Rubenstein JL, Nicolas JF (1986) EMBO J 5:3133–3142.
13186  www.pnas.orgcgidoi10.1073pnas.0705464104 Zhao et al.
